Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations
- PMID: 12678879
- DOI: 10.2174/1381612033455350
Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations
Abstract
Leptin has emerged as a major regulator of body adiposity. The majority of humans with obesity have a resistance to leptin. Human and rodent studies indicate that the major cause of this resistance arises from an impaired ability of leptin to cross the blood-brain barrier, with lesser roles played by receptor and post-receptor defects. Evidence from baboons living in the wild is consistent with the hypothesis that during most of evolution serum levels of leptin were much lower than those currently considered normal. Leptin may have evolved to signal to the brain when caloric reserves were adequate to engage in reproductive and other behaviors not immediately concerned with acquisition of calories. The leptin transporter is a regulated system, with the rate of transport being increased by alpha(1) adrenergic agents and decreased by starvation. Impaired regulation of the transporter or impairments in transporter production could underlie the resistance caused by transporter defects. Evolutionary pressures would not have selected against such impairments if leptin levels were lower than those typically seen in Western society. A model that could explain how leptin transporter resistance can be acquired is presented.
Similar articles
-
The blood-brain barrier as a cause of obesity.Curr Pharm Des. 2008;14(16):1606-14. doi: 10.2174/138161208784705496. Curr Pharm Des. 2008. PMID: 18673202 Review.
-
Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene.Brain Res. 2002 Sep 20;950(1-2):130-6. doi: 10.1016/s0006-8993(02)03013-5. Brain Res. 2002. PMID: 12231237
-
Impaired transport of leptin across the blood-brain barrier in obesity.Peptides. 1999 Nov;20(11):1341-5. doi: 10.1016/s0196-9781(99)00139-4. Peptides. 1999. PMID: 10612449
-
Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity.Curr Pharm Des. 2001 Jan;7(2):125-33. doi: 10.2174/1381612013398310. Curr Pharm Des. 2001. PMID: 11172704 Review.
-
Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor.Peptides. 1999 Dec;20(12):1449-53. doi: 10.1016/s0196-9781(99)00156-4. Peptides. 1999. PMID: 10698121
Cited by
-
Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.Free Radic Biol Med. 2011 Apr 1;50(7):801-10. doi: 10.1016/j.freeradbiomed.2010.12.029. Epub 2010 Dec 28. Free Radic Biol Med. 2011. PMID: 21193030 Free PMC article.
-
Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells.J Neurochem. 2010 Dec;115(5):1288-98. doi: 10.1111/j.1471-4159.2010.07028.x. Epub 2010 Oct 26. J Neurochem. 2010. PMID: 20977476 Free PMC article.
-
Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.Oxid Med Cell Longev. 2018 Feb 14;2018:2468457. doi: 10.1155/2018/2468457. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29636836 Free PMC article. Review.
-
Acute changes in systemic glycemia gate access and action of GLP-1R agonist on brain structures controlling energy homeostasis.Cell Rep. 2022 Nov 22;41(8):111698. doi: 10.1016/j.celrep.2022.111698. Cell Rep. 2022. PMID: 36417883 Free PMC article.
-
Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.J Proteome Res. 2006 Oct;5(10):2505-22. doi: 10.1021/pr0603349. J Proteome Res. 2006. PMID: 17022621 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical